ENDRA Life Sciences Inc [NASDAQ: NDRA] stock went on a downward path that fall over -14.84% on Wednesday, amounting to a one-week price decrease of less than -22.43%.
Over the last 12 months, NDRA stock dropped by -99.53%. The one-year ENDRA Life Sciences Inc stock forecast points to a potential upside of 97.8. The average equity rating for NDRA stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $3.98 million, with 18.14 million shares outstanding and 18.14 million shares in the current float. Compared to the average trading volume of 10.27M shares, NDRA stock reached a trading volume of 6095994 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on ENDRA Life Sciences Inc [NDRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NDRA shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NDRA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for ENDRA Life Sciences Inc is set at 0.07 The Price to Book ratio for the last quarter was 0.04, with the Price to Cash per share for the same quarter was set at 0.35.
NDRA Stock Performance Analysis:
ENDRA Life Sciences Inc [NDRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -22.43. With this latest performance, NDRA shares gained by 13.52% in over the last four-week period, additionally sinking by -98.64% over the last 6 months – not to mention a drop of -99.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NDRA stock in for the last two-week period is set at 39.34, with the RSI for the last a single of trading hit 40.64, and the three-weeks RSI is set at 34.21 for ENDRA Life Sciences Inc [NDRA]. The present Moving Average for the last 50 days of trading for this stock 0.2539, while it was recorded at 0.2533 for the last single week of trading, and 16.8805 for the last 200 days.
Insight into ENDRA Life Sciences Inc Fundamentals:
ENDRA Life Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.97 and a Current Ratio set at 4.97.
ENDRA Life Sciences Inc [NDRA] Institutonal Ownership Details
There are presently around $0.09%, or 0.09%% of NDRA stock, in the hands of institutional investors.
